Publications To Date


    Filter Publications

    PAGE 10 OF 86 | DISPLAYING 136 - 150 OF 1279 RESULTS

    Caetano MS et al., Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses., , Clin Cancer Res, Sep 20, 2019

    Robinson MH et al., Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma., , Sci Rep, Sep 20, 2019

    Schreiber LM et al., The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer., , Br J Cancer, Sep 18, 2019

    Ronsley R et al., The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study., , Pediatr Hematol Oncol, Sep 18, 2019

    Adamo B et al., Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial., , Breast Cancer Res, Sep 18, 2019

    Octeau D et al., Outcome-Related Differences in Gene Expression Profiles of High Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy., , Mol Cancer Res, Sep 17, 2019

    Li C et al., The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality, , Immunity., Sep 17, 2019

    Staiger AM et al., A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL., , Leukemia, Sep 17, 2019

    Park IH et al., Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer., , Sci Rep, Sep 16, 2019

    Penyige A et al., Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients., , Int J Mol Sci, Sep 13, 2019

    Li K et al., Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma., , Sci Rep, Sep 13, 2019

    Penyige A et al., Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients., , Int J Mol Sci, Sep 13, 2019

    Haratani K et al., Clinical and immune profiling for cancer of unknown primary site., , J Immunother Cancer, Sep 13, 2019

    Roberto D et al., Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci., , Prostate, Sep 10, 2019

    McQuerry et al., Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes, , BMC Cancer., Sep 10, 2019